DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Pokorny T, Preller KH, Kraehenmann R. et al.
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.
Eur Neuropsychopharmacology 2016;
26: 756-766
We do not assume any responsibility for the contents of the web pages of other providers.